Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.

Por Mitsuya, H, Broder, S
Publicado em 1986

Pharmacological inhibition of in vitro infectivity of human T lymphotropic virus type I.

Por Matsushita, S, Mitsuya, H, Reitz, M S, Broder, S
Publicado em 1987

Targeted and highly efficient gene transfer into CD4+ cells by a recombinant human immunodeficiency virus retroviral vector.

Por Shimada, T, Fujii, H, Mitsuya, H, Nienhuis, A W
Publicado em 1991

Disparate actions of hydroxyurea in potentiation of purine and pyrimidine 2',3'-dideoxynucleoside activities against replication of human immunodeficiency virus.

Por Gao, W Y, Johns, D G, Chokekuchai, S, Mitsuya, H
Publicado em 1995

Adenallene and cytallene: acyclic-nucleoside analogues that inhibit replication and cytopathic effect of human immunodeficiency virus in vitro.

Por Hayashi, S, Phadtare, S, Zemlicka, J, Matsukura, M, Mitsuya, H, Broder, S
Publicado em 1988

Decreased suppressor T cell activity in patients with hepatic cirrhosis (HC).

Por Tomino, S, Fujiwara, H, Kagimoto, T, Mitsuya, H, Nishimura, H, Kishimoto, S
Publicado em 1982

Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells.

Por Gao, W Y, Shirasaka, T, Johns, D G, Broder, S, Mitsuya, H
Publicado em 1993

Broad spectrum antiretroviral activity of 2',3'-dideoxynucleosides.

Por Dahlberg, J E, Mitsuya, H, Blam, S B, Broder, S, Aaronson, S A
Publicado em 1987

Comparative analysis of anti-human immunodeficiency virus type 1 activities of dideoxynucleoside analogs in resting and activated peripheral blood mononuclear cells.

Por Shirasaka, T, Chokekijchai, S, Yamada, A, Gosselin, G, Imbach, J L, Mitsuya, H
Publicado em 1995

Human monoclonal antibody directed against an envelope glycoprotein of human T-cell leukemia virus type I.

Por Matsushita, S, Robert-Guroff, M, Trepel, J, Cossman, J, Mitsuya, H, Broder, S
Publicado em 1986

In vitro inhibition of the infectivity and replication of human immunodeficiency virus type 1 by combination of antiretroviral 2',3'-dideoxynucleosides and virus-binding inhibitors...

Por Hayashi, S, Fine, R L, Chou, T C, Currens, M J, Broder, S, Mitsuya, H
Publicado em 1990

Central nervous system targeting of 2',3'-dideoxyinosine via adenosine deaminase-activated 6-halo-dideoxypurine prodrugs.

Por Morgan, M E, Chi, S C, Murakami, K, Mitsuya, H, Anderson, B D
Publicado em 1992

Alterations in cytotoxic and helper T cell function after infection of T cell clones with human T cell leukemia virus, type I.

Por Yarchoan, R, Guo, H G, Reitz, M, Maluish, A, Mitsuya, H, Broder, S
Publicado em 1986

Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus.

Por Matsukura, M, Shinozuka, K, Zon, G, Mitsuya, H, Reitz, M, Cohen, J S, Broder, S
Publicado em 1987

PDK1 inhibition is a novel therapeutic target in multiple myeloma

Por Fujiwara, S, Kawano, Y, Yuki, H, Okuno, Y, Nosaka, K, Mitsuya, H, Hata, H
Publicado em 2013

Lipophilic halogenated congeners of 2',3'-dideoxypurine nucleosides active against human immunodeficiency virus in vitro.

Por Shirasaka, T, Murakami, K, Ford, H, Kelley, J A, Yoshioka, H, Kojima, E, Aoki, S, Broder, S, Mitsuya, H
Publicado em 1990

Removal of human immunodeficiency virus type 1 (HIV-1) protease inhibitors from preparations of immature HIV-1 virions does not result in an increase in infectivity or the appearan...

Por Humphrey, R W, Ohagen, A, Davis, D A, Fukazawa, T, Hayashi, H, Höglund, S, Mitsuya, H, Yarchoan, R
Publicado em 1997

Protein binding of human immunodeficiency virus protease inhibitor KNI-272 and alteration of its in vitro antiretroviral activity in the presence of high concentrations of proteins...

Por Kageyama, S, Anderson, B D, Hoesterey, B L, Hayashi, H, Kiso, Y, Flora, K P, Mitsuya, H
Publicado em 1994

PU.1 induces apoptosis in myeloma cells through direct transactivation of TRAIL

Por Ueno, S, Tatetsu, H, Hata, H, Iino, T, Niiro, H, Akashi, K, Tenen, DG., Mitsuya, H, Okuno, Y
Publicado em 2009

Cyclobut-A and cyclobut-G, carbocyclic oxetanocin analogs that inhibit the replication of human immunodeficiency virus in T cells and monocytes and macrophages in vitro.

Por Hayashi, S, Norbeck, D W, Rosenbrook, W, Fine, R L, Matsukura, M, Plattner, J J, Broder, S, Mitsuya, H
Publicado em 1990